Intelligence Β· Clinical Pipeline

Structure Therapeutics Pipeline

All ClinicalTrials.gov programs at Structure Therapeutics β€” phase, modality, and trial IDs.

Programs
4

Quick answer

Structure Therapeutics has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. A phase 1 study to assess the mass balance, pharmacokinetics, metabolism, and excretion of GSBR-1290, containing a microtracer dose of [14C] GSBR-1290, in healthy participants

    Structure Therapeutics

    Not applicable - Healthy volonteers

    phase 1 other active

    1 trial
  2. GSBR-1290

    Structure Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  3. GSBR-1290 (Capsule/Tablet)

    Structure Therapeutics

    Healthy Volunteers

    phase 1 small molecule active

    1 trial
  4. TG-0054

    Structure Therapeutics

    Healthy

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does Structure Therapeutics have?

4 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs